4-aminopyridine has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceña, V; Fariñas, I; González-García, C; Martín, ED; Milán, M | 1 |
| Chen, L; Dong, S; Li, S; Li, Y; Mao, Z; Wang, D; Wei, D; Yan, X | 1 |
2 other study(ies) available for 4-aminopyridine and alpha-synuclein
| Article | Year |
|---|---|
Stressor-related impairment of synaptic transmission in hippocampal slices from alpha-synuclein knockout mice.
Topics: 4-Aminopyridine; Adenosine; alpha-Synuclein; Analgesics; Anesthetics, Local; Animals; Blotting, Western; Drug Interactions; Excitatory Postsynaptic Potentials; Hippocampus; Hypoxia; In Vitro Techniques; Mice; Mice, Knockout; Nerve Tissue Proteins; Neurons; Potassium Channel Blockers; Synaptic Transmission; Synucleins; Tetrodotoxin; Theophylline; Time Factors | 2004 |
Design, synthesis, immunocytochemistry evaluation, and molecular docking investigation of several 4-aminopyridine derivatives as potential neuroprotective agents for treating Parkinson's disease.
Topics: 4-Aminopyridine; alpha-Synuclein; Animals; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Design; Humans; Immunohistochemistry; Molecular Docking Simulation; Molecular Structure; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Protein Kinase Inhibitors; Rats; rho-Associated Kinases; Structure-Activity Relationship | 2017 |